In a study conducted by Montes et al., compared with healthy donors, patients with MDS and sAML have significantly reduced counts of both CD4+ T lymphocytes and NK cells, with sAML having a higher count of CD4+ T lymphocytes than MDS, but lower than healthy donors. The gene discussed is CD4; the disease is myelodysplastic syndrome.